Antihypertensive Agent

Researchers determined that nearly 500,000 people from England, Scotland and Wales should have initiated BP-lowering medication but did not during the first year-plus of the COVID-19 pandemic.

Patients taking antihypertensive medication in the evening experienced no difference in MI, stroke or CV death occurrence compared with patients taking them in the morning, a speaker reported.

Poststroke antihypertensive medication use did not differ in rural and urban residents, according to study findings published in the Journal of the American Heart Association.

Pfizer issued a voluntarily nationwide recall of five lots of quinapril HCl/hydrochlorothiazide tablets due to the presence of a nitrosamine known to be carcinogenic in high doses.

Pfizer has issued a voluntarily recall of certain lots of quinapril HCl/hydrochlorothiazide tablets and additional lots distributed by Greenstone due to high levels of a nitrosamine known to be carcinogenic in high doses.

Young and middle-aged adults whose systolic BP rose at least 6.5 mm Hg upon standing were more likely to have CV and renal events later in life compared with others, researchers reported in Hypertension.

The combination of healthy lifestyle and adherence to antihypertensive medications was associated with decreased risk for mortality in patients with hypertension, according to data in JAMA Network Open.

According to a new scientific statement published in Hypertension, high BP should be treated during pregnancy, and treatment should be individualized to each patient.

Quarter doses of four antihypertensive medications vs. monotherapy in patients with hypertension.

Low-cost antihypertensive drugs appeared associated with reductions in colorectal cancer-specific mortality among patients with stage I to stage III disease, according to results of a retrospective analysis published in Cancer Medicine.